72 results
DEFA14A
ABOS
Acumen Pharmaceuticals Inc
22 Apr 24
Additional proxy soliciting materials
4:31pm
of Directors of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. 3. To conduct
S-8
EX-23.2
feo50xfk weml
27 Mar 24
Registration of securities for employees
4:02pm
S-8
EX-5.1
666vicfy3g
27 Mar 24
Registration of securities for employees
4:02pm
S-8
a53nrb9t ksus
27 Mar 24
Registration of securities for employees
4:02pm
8-K
EX-99.1
82k jw8cbk7nag
19 Mar 24
Corporate Presentation March 2024 1
8:05am
8-K
1ze6ww
19 Mar 24
Corporate Presentation March 2024 1
8:05am
8-K
EX-99.1
xxf9 fly06onrk2k
12 Jan 24
Corporate Presentation January 2024 1
8:42am
8-K
EX-99.1
76t9e8qx97 homwnm
4 Dec 23
Corporate Presentation December 2023 1
7:45am
8-K
EX-99.1
jnr trzsqm3
13 Nov 23
Corporate Presentation November 2023 1
5:10pm
424B5
clifky3nn ar9o
20 Jul 23
Prospectus supplement for primary offering
4:11pm